cambridge's bluebird bio licenses delivery tech to novartis, gsk.arabic.
�this negligence must not be allowed to continue,� budkie�s letter states. �the university of california, berkeley, has clearly failed to follow federal regulations and guidelines.�.3000.
.
the house has passed an order extending the public health committee's reporting deadline for cusack's bill..
classifieds
.
�now we know the astonishing truth that some patients are waiting a year or more just to get treatment. it�s simply not good enough.�.
.
.
please wait�
.
..
..treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk (file pic)